Bernardo Wealth Planning’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-78,578
| Closed | -$25.6K | – | 94 |
|
|
2023
Q2 | $25.6K | Buy |
78,578
+40,000
| +104% | +$13K | 0.01% | 90 |
|
|
2023
Q1 | $16.6K | Hold |
38,578
| – | – | 0.01% | 90 |
|
|
2022
Q4 | $20.4K | Buy |
38,578
+8,109
| +27% | +$4.3K | 0.01% | 88 |
|
|
2022
Q3 | $20K | Hold |
30,469
| – | – | 0.01% | 81 |
|
|
2022
Q2 | $34K | Hold |
30,469
| – | – | 0.02% | 82 |
|
|
2022
Q1 | $62K | Hold |
30,469
| – | – | 0.03% | 89 |
|
|
2021
Q4 | $87K | Buy |
30,469
+1,650
| +6% | +$4.71K | 0.04% | 85 |
|
|
2021
Q3 | $122K | Buy |
28,819
+1,600
| +6% | +$6.77K | 0.07% | 76 |
|
|
2021
Q2 | $143K | Hold |
27,219
| – | – | 0.09% | 76 |
|
|
2021
Q1 | $126K | Hold |
27,219
| – | – | 0.08% | 75 |
|
|
2020
Q4 | $89K | Hold |
27,219
| – | – | 0.03% | 171 |
|
|
2020
Q3 | $90K | Buy |
27,219
+800
| +3% | +$2.65K | 0.04% | 154 |
|
|
2020
Q2 | $89K | Hold |
26,419
| – | – | 0.05% | 137 |
|
|
2020
Q1 | $101K | Hold |
26,419
| – | – | 0.07% | 130 |
|
|
2019
Q4 | $159K | Hold |
26,419
| – | – | 0.1% | 160 |
|
|
2019
Q3 | $199K | Hold |
26,419
| – | – | 0.14% | 152 |
|
|
2019
Q2 | $358K | Buy |
26,419
+1,000
| +4% | +$13.6K | 0.28% | 99 |
|
|
2019
Q1 | $138K | Buy |
25,419
+1,278
| +5% | +$6.94K | 0.11% | 145 |
|
|
2018
Q4 | $72K | Buy |
+24,141
| New | +$72K | 0.06% | 130 |
|